Steven Bishop
Seminars
Wednesday 30th September 2026
From Images to Insight: Qureight’s AI-Powered Platform for Precision Clinical Trials
5:00 pm
- Introducing Qureight’s end-to-end imaging ecosystem spanning imaging CRO services, central reads and AI-powered quantitative biomarkers
- Important lessons from recent IPF and PPF studies demonstrating how imaging is improving patient selection, endpoint assessment and trial efficiency
- How integrated imaging and biomarker strategies are shaping the next generation of antifibrotic clinical trials
- Why fibrosis burden is the principal structural imaging biomarker for antifibrotic drug development and the leading candidate imaging endpoint
